Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.96 CHF | -1.49% | +11.33% | +128.08% |
Apr. 24 | Kuros Biosciences Posts Higher Q1 Product Sales | MT |
Apr. 17 | Kuros Biosciences AG Approves Board of Director and Committee Changes | CI |
Sales 2022 | 17.99M 19.78M | Sales 2023 | 33.56M 36.91M | Capitalization | 128M 141M |
---|---|---|---|---|---|
Net income 2022 | -14M -15.39M | Net income 2023 | -13M -14.29M | EV / Sales 2022 | 1.76 x |
Net cash position 2022 | 22.08M 24.28M | Net cash position 2023 | 12M 13.19M | EV / Sales 2023 | 3.46 x |
P/E ratio 2022 |
-3.41
x | P/E ratio 2023 |
-9.18
x | Employees | 80 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 64.77% |
1 day | -1.49% | ||
1 week | +11.33% | ||
Current month | +22.84% | ||
1 month | +3.78% | ||
3 months | +34.46% | ||
6 months | +99.50% | ||
Current year | +128.08% |
Managers | Title | Age | Since |
---|---|---|---|
Joost de Bruijn
FOU | Founder | 58 | 17-12-03 |
Christopher Fair
CEO | Chief Executive Officer | 54 | 21-04-18 |
Daniel Geiger
DFI | Director of Finance/CFO | - | 23-02-16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Scott P. Bruder
BRD | Director/Board Member | 62 | 18-06-13 |
Christopher Fair
CEO | Chief Executive Officer | 54 | 21-04-18 |
Joost de Bruijn
FOU | Founder | 58 | 17-12-03 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 7.96 | -1.49% | 291,041 |
24-05-16 | 8.08 | +1.00% | 252,390 |
24-05-15 | 8 | +10.50% | 410,655 |
24-05-14 | 7.24 | -1.90% | 81,891 |
24-05-13 | 7.38 | +3.22% | 184,895 |
Delayed Quote Swiss Exchange, May 17, 2024 at 11:30 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+128.08% | 330M | |
+9.42% | 114B | |
+11.84% | 104B | |
-14.15% | 22.41B | |
-1.05% | 22.28B | |
-5.29% | 19.07B | |
-38.29% | 18B | |
-4.16% | 17.89B | |
+7.99% | 14.28B | |
+36.24% | 12.55B |
- Stock Market
- Equities
- KURN Stock